ATORVASTATIN for Prostate cancer: Side Effects & Safety Data
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
There are 16 adverse event reports in the FDA FAERS database where ATORVASTATIN was used for Prostate cancer.
Most Reported Side Effects for ATORVASTATIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Type 2 diabetes mellitus | 7,556 | 9.5% | 84 | 166 |
| Myalgia | 7,155 | 9.0% | 233 | 1,230 |
| Drug hypersensitivity | 3,929 | 4.9% | 8 | 147 |
| Drug ineffective | 3,865 | 4.9% | 80 | 1,134 |
| Fatigue | 3,439 | 4.3% | 237 | 1,096 |
| Arthralgia | 3,338 | 4.2% | 239 | 642 |
| Rhabdomyolysis | 3,286 | 4.1% | 330 | 2,298 |
| Dyspnoea | 3,137 | 3.9% | 313 | 1,516 |
| Nausea | 2,888 | 3.6% | 237 | 1,298 |
| Asthenia | 2,791 | 3.5% | 291 | 1,200 |
| Headache | 2,747 | 3.5% | 228 | 940 |
| Pain | 2,700 | 3.4% | 20 | 1,000 |
| Malaise | 2,614 | 3.3% | 222 | 1,261 |
| Muscle spasms | 2,581 | 3.3% | 12 | 408 |
| Pain in extremity | 2,522 | 3.2% | 23 | 637 |
Other Indications for ATORVASTATIN
Product used for unknown indication (22,764)
Blood cholesterol increased (10,139)
Hypercholesterolaemia (5,615)
Dyslipidaemia (4,796)
Cardiovascular event prophylaxis (4,792)
Low density lipoprotein increased (4,713)
Hyperlipidaemia (3,648)
Blood cholesterol abnormal (2,024)
Blood cholesterol (1,722)
Blood triglycerides increased (1,638)
Other Drugs Used for Prostate cancer
LEUPROLIDE (45,399)
ENZALUTAMIDE (25,954)
RELUGOLIX (18,752)
ABIRATERONE (12,209)
APALUTAMIDE (3,286)
GOSERELIN (2,080)
DEGARELIX (2,035)
BICALUTAMIDE (1,832)
SIPULEUCEL-T (1,720)
DENOSUMAB (1,627)